The evidence for lipid lowering: type 2 diabetes and coronary heart disease risk.
Recent research suggests the risk of heart disease in patients with or without diabetes can be cut dramatically by prescribing cholesterol-lowering drugs more aggressively. But is there enough evidence yet to justify changed practice? While nurses need to keep up with these developments, their educating and supporting role is still vital.
Townsend
Delyth
D
Wales Heart Research Institute, Bro Morgannwg NHS Trust, Bridgend. Delyth.Townsend@bromor-tr.wales.nhs.uk
Davis
Ruth
R
D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000209:etiology / Q000451:nursing / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000451:nursing; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D012307:Risk Factors
D000960:Hypolipidemic Agents